Vimarsana
Biggest News Aggregation in the World

Page 5 - Systemic Sclerosis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Systemic Sclerosis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Systemic Sclerosis Today - Breaking & Trending Today

BioSenic provides further update on negotiations with its main creditors - Vimarsana News

BioSenic provides further update on negotiations with its main creditors

INSIDE INFORMATION Agreement with the main creditors of BioSenic for a standstill running until October 2023 Mont-Saint-Guibert, Belgium, July 10th, 2023, 7.00 am CEST – BIOSENIC ,...

BioSenic provides financial update - Vimarsana News

BioSenic provides financial update

INSIDE INFORMATION Launch of negotiation with main creditors Agreement with Global Tech Opportunities (GTO) to secure short term financing Mont-Saint-Guibert, Belgium, June 30, 2023, 7.00 am CEST – BIOSENIC (Euronext Brussels and Paris: BIOS), the innovative company addressing unmet medical needs in the areas of innate immunity, inflammation and organ/function repair, today provides a financial update. BioSenic has obtained an official appointment of Yves Brulard to reach a negotiated agreement

Source: yahoo.com
[Latest] Global Surgical Tubing Market Size/Share Worth USD - Vimarsana News

[Latest] Global Surgical Tubing Market Size/Share Worth USD

[228+ Pages Study] The global surgical tubing market size is estimated to grow USD 4200 million by 2030, at a CAGR of 8.0% between 2023 and 2030. The...

Systemic Sclerosis Without Skin Fibrosis Can Still Be Severe - Vimarsana News

Systemic Sclerosis Without Skin Fibrosis Can Still Be Severe

Nearly half of these patients had interstitial lung disease and had similar rates of scleroderma renal crisis, compared with the other disease subtypes.

NEW PUBLICATION SUPPORTS THE USE OF CALDOLOR® IN NEWBORN PEDIATRIC PATIENTS - Vimarsana News

NEW PUBLICATION SUPPORTS THE USE OF CALDOLOR® IN NEWBORN PEDIATRIC PATIENTS

NASHVILLE, Tenn., June 26, 2023 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today announced the publication of positive results from a clinical study investigating the safety and pharmaco...